Conditional sentence

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

Retrieved on: 
Tuesday, March 5, 2024

Through this partnership, Better Therapeutics is committed to making one million prescriptions of its U.S. Food and Drug Administration (FDA)-authorized product, AspyreRx , available to support underserved patients through 1,400 Federally Qualified Health Center (FQHC) organizations.

Key Points: 
  • Through this partnership, Better Therapeutics is committed to making one million prescriptions of its U.S. Food and Drug Administration (FDA)-authorized product, AspyreRx , available to support underserved patients through 1,400 Federally Qualified Health Center (FQHC) organizations.
  • This underscores the urgent need for evidence-based interventions to ensure equitable access to high-quality care for all.
  • The Lifestyle Medicine National Training Initiative (NTI) is an extension of ACLM’s $24.1 million commitment to the 2022 White House Conference on Hunger, Health, and Nutrition .
  • Better Therapeutics and ACLM are seeking additional partners and funding to support the implementation and maximize the initiative’s impact.

Roseman University College of Nursing Launches Doctoral Program for Nurse Anesthetists

Retrieved on: 
Monday, March 4, 2024

The College of Nursing at Roseman University of Health Sciences today announced its new Doctor of Nursing Practice in Nurse Anesthesia (DNPNA) program to address the national demand for Certified Registered Nurse Anesthetists (CRNAs).

Key Points: 
  • The College of Nursing at Roseman University of Health Sciences today announced its new Doctor of Nursing Practice in Nurse Anesthesia (DNPNA) program to address the national demand for Certified Registered Nurse Anesthetists (CRNAs).
  • The program, approved by the Council on Accreditation of Nurse Anesthesia Educational Programs (COA), is accepting applications for an inaugural class starting in July 2024.
  • “Roseman’s DNPNA students will learn how to administer anesthesia and deliver anesthesia-related services independently and as part of an interprofessional team.
  • “We are delighted to launch this new program to prepare nurses for one of the most in-demand and critical roles in health care,” says Brian Oxhorn, PhD, RN, dean of Roseman University College of Nursing.

Children’s Hospital Los Angeles Launches Ninth Annual Make March Matter® Fundraising Campaign

Retrieved on: 
Friday, March 1, 2024

Children’s Hospital Los Angeles (CHLA) launched its ninth annual Make March Matter campaign Friday.

Key Points: 
  • Children’s Hospital Los Angeles (CHLA) launched its ninth annual Make March Matter campaign Friday.
  • View the full release here: https://www.businesswire.com/news/home/20240301906127/en/
    Children's Hospital Los Angeles kicks off its ninth annual Make March Matter fundraising campaign.
  • Make March Matter is an annual fundraising campaign that builds awareness and support for children’s health in Los Angeles.
  • The goal of the campaign is to raise money in support of Children’s Hospital Los Angeles to ensure that all of its pediatric patients receive the critical, lifesaving care they need.

Global Therapeutic Antibody Market Forecast to Reach USD 428.20 Billion by 2029: In-Depth Analysis by Antibody Type, Source, and Application - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 29, 2024

Global Therapeutic Antibody Market reveals significant insights into market segmentation, including monoclonal antibodies, bispecific antibodies, and more.

Key Points: 
  • Global Therapeutic Antibody Market reveals significant insights into market segmentation, including monoclonal antibodies, bispecific antibodies, and more.
  • This in-depth report examines the forecast growth trends and market dynamics from 2024 to 2029, with a specific focus on key regions and countries contributing to the global market expansion.
  • The market is analyzed by product type, source, and application, offering a thorough understanding of the therapeutic antibody landscape.
  • Through a careful examination of industry trends, drivers, and challenges, the report provides an insightful forecast and analysis that bolsters understanding of the Global Therapeutic Antibody Market's future trajectory.

Ontrak Health Bolsters Strategic Partnership with Sentara Health Plans

Retrieved on: 
Thursday, February 29, 2024

Ontrak Health (NASDAQ: OTRK), a leading AI-powered and tech-enabled behavioral healthcare company, today announced the expansion of its strategic partnership with Sentara Health Plans in the Commonwealth of Virginia.

Key Points: 
  • Ontrak Health (NASDAQ: OTRK), a leading AI-powered and tech-enabled behavioral healthcare company, today announced the expansion of its strategic partnership with Sentara Health Plans in the Commonwealth of Virginia.
  • Sentara Health Plans is the health plan division of Sentara Health, an integrated health care delivery system, one of the largest health systems in the U.S. Mid-Atlantic and Southeast.
  • The expanded partnership more than quadruples the number of Sentara Health Plans commercial members who are eligible for the Ontrak WholeHealth+ program, and is the first of several expansion opportunities we are working on together to finalize.
  • Mary Lou Osborne, President and Chief Commercial Officer of Ontrak Health, expressed gratitude for the long-standing partnership and business expansion stating, “It is a privilege to work with Sentara Health Plans leaders prioritizing behavioral health solutions for its members, and we are thrilled to expand Ontrak Health services to a larger commercial population.

Delta Dental of Tennessee’s Smile180 Foundation and Tennessee PBS KIDS Stations Launch “Healthy Smiles” Educational Campaign

Retrieved on: 
Thursday, February 29, 2024

Delta Dental of Tennessee’s charitable arm, the Smile180 Foundation , today announced the launch of a statewide oral health education campaign in partnership with PBS KIDS stations across Tennessee.

Key Points: 
  • Delta Dental of Tennessee’s charitable arm, the Smile180 Foundation , today announced the launch of a statewide oral health education campaign in partnership with PBS KIDS stations across Tennessee.
  • View the full release here: https://www.businesswire.com/news/home/20240228363799/en/
    “I am thrilled to announce the launch of our Healthy Smiles campaign in partnership with PBS KIDS stations across Tennessee,” said Jeff Ballard, President & CEO of Delta Dental of Tennessee.
  • To access the “Healthy Smiles” PSAs, educational materials, and other resources in one place, visit the Delta Dental of Tennessee Kids Corner.
  • Along with its corporate foundation, Smile180, Delta Dental of Tennessee donated more than $4.0 million in funding and in-kind services to over 100 organizations in 2023.

Global Insulin Pen Market Report 2024: A $14.1 Billion Forecasted Market by 2028, Registering Compound Annual Growth Rate of 6% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 28, 2024

The global insulin pen market was valued at $9.9 billion in 2022.

Key Points: 
  • The global insulin pen market was valued at $9.9 billion in 2022.
  • The market is expected to grow at a compound annual growth rate (CAGR) of 6.1%, reaching $14.1 billion by the end of 2028.
  • In 2022, the reusable insulin pen segment held the highest market share at about 51.5%, followed by disposable pens at 48.5%.
  • This report thoroughly examines the worldwide market size of global insulin pen delivery technology, enhancing its appeal to stakeholders and readers alike.

OM1 to Present Research on Multiple Sclerosis at ACTRIMS Forum 2024

Retrieved on: 
Tuesday, February 27, 2024

The poster will focus on the use of an AI based estimation model used to help characterize disease progression in multiple sclerosis (MS) subtypes using real-world data (RWD).

Key Points: 
  • The poster will focus on the use of an AI based estimation model used to help characterize disease progression in multiple sclerosis (MS) subtypes using real-world data (RWD).
  • WHEN: The presentation will be held on the first day of ACTRIMS Forum 2024 on Thursday, February 29 between 6:00 – 7:30 pm ET.
  • WHY: To effectively monitor disease progression in patients with MS, the measurement of disability is an important component.
  • For insights specific to OM1’s work with multiple sclerosis, including the company’s PremiOM MS dataset, visit the website page here .

Global Respiratory Devices Market to Exhibit Strong Growth by 2027 - An In-depth Industry Analysis and Trends Overview - ResearchAndMarkets.com

Retrieved on: 
Monday, February 26, 2024

The Global Respiratory Devices market which grew at a robust CAGR from 2017-2022 & is forecasted to grow steadily from 2022-2027 driven by increase in respiratory illness cases, innovative technologies alongside growing inorganic growth strategies.

Key Points: 
  • The Global Respiratory Devices market which grew at a robust CAGR from 2017-2022 & is forecasted to grow steadily from 2022-2027 driven by increase in respiratory illness cases, innovative technologies alongside growing inorganic growth strategies.
  • The rapid growth in global geriatric population, rising incidents of chronic diseases (including COPD & asthma), alongside the cost advantage of home care devices & services are the key factors driving the global respiratory devices market.
  • The Global Respiratory Devices Market is fragmented with players occupying almost half of the market.
  • The Global Respiratory Devices Market witnessed significant growth during the period 2017-2022, owing to increase in fast fashion trends, Enhancing Service Offerings alongside increase in product innovativeness.

Global IV Catheters Market Insights Report 2023-2029: Peripheral Inserted Central Catheters (PICCs) Leading the Charge - ResearchAndMarkets.com

Retrieved on: 
Friday, February 23, 2024

The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%

Key Points: 
  • The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%
    The global IV catheters market report contains exclusive data on 33 vendors.
  • BD, B Braun, Terumo, Teleflex, ICU Medical, and Nipro Medical are some leading players currently dominating the global IV catheters market.
  • The continuous growth in individuals with chronic conditions and the rapidly expanding elderly population are the primary factors fueling the global demand for peripheral IV catheters.
  • The peripheral inserted central catheters (PICCs) product segment accounted for the highest market share of over 45% of the global CIVCs market.